Lisata Therapeutics, Inc. (LSTA) vs NeuroSense Therapeutics Ltd. (NRSN)

Lisata Therapeutics, Inc. and NeuroSense Therapeutics Ltd. are both Biotechnology companies. Lisata Therapeutics, Inc. and NeuroSense Therapeutics Ltd. are of similar size ($14.0M and $13.5M). Across the 7 metrics below, NeuroSense Therapeutics Ltd. leads on 4 and Lisata Therapeutics, Inc. on 3.

Valuation

Metric LSTA NRSN Biotechnology median
P/E n/m n/m 7.88
P/S 0.95 n/m 11.47
P/B 1.80 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 0.28 n/m 10.73
Earnings yield (103.80%) (179.97%) (28.84%)
Free cash flow yield (85.85%) (339.53%) (23.03%)

Profitability

Metric LSTA NRSN Biotechnology median
Gross margin 0.49% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (101.66%) 0.00% (57.72%)
Return on assets (80.81%) 0.00% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LSTA NRSN Biotechnology median
Revenue growth (TTM) (24.67%) — 5.64%
EPS growth (last fiscal year) 20.42% 20.45% —
Revenue growth, 5-year CAGR (20.28%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LSTA NRSN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.69 0.71 4.73
Net debt to EBITDA 0.88 0.01 0.96

Dividend

Metric LSTA NRSN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric LSTA NRSN Biotechnology median
Market cap 13.52m 14.04m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack